Veterinary Vaccines Market
Advances in Animal Immunization Development Technology Drive Up Demand for Veterinary Vaccines. FMI Tracks the Demand across 30+ Countries.
Veterinary Vaccines Market by Product, Disease, Distribution Channel, Species & Region | Forecast (2023 to 2033)
Veterinary Vaccines Market Outlook (2023 to 2033)
The net worth of the market share of veterinary vaccines is predicted to grow from US$ 11.3 Billion in 2023 to over US$ 20.82 billion by 2033. This is expected to further drive the market share of veterinary vaccines and register a CAGR of 6.2% between 2023 and 2033.
By controlling and preventing serious epidemic diseases, veterinary vaccines are often crucial to animal health protection. Throughout the forecast years, the veterinary vaccines market is expected to grow due primarily to the high adoption of pet animals across the globe.
This is due to increased expenditure on pet care, and increased adoption of efficient immunizations. For instance, Americans spent US$ 69.51 billion in 2017 on their pets, according to the Annual Industry-wide Spending Figures at the Global Pet Expo in Orlando, Florida.
In recent years, zoonotic diseases have become increasingly common and have led to a rise in interest in companion animal vaccines. A key factor contributing to advancement in this field is the emergence of new zoonotic diseases, government investments, and pet lovers' increased expenditures on animal health.
As a result of the development of novel vaccines that can target dangerous zoonotic diseases such as E. coli O157:H7. E. coli O157:H7 is a foodborne disease that can cause HUS and kidney failure. Veterinary vaccines have made a significant impact on human health, welfare, and production in recent years.
As a result of novel research in the field, the market for veterinary vaccines is expected to grow. This is because more vaccines are developed, adjuvants are developed, and pharmaceutical residuals are reduced in the human food chain.
In addition, the persistent economic slowdown, rising storage costs, and an increase in vegetarianism are significant factors limiting the market. With reduced costs, more investments in animal health, and skilled professionals, this market could have lucrative growth prospects.
|
Attributes |
Details |
|
Veterinary Vaccines Market Value (2023) |
US$ 11.3 Billion |
|
Veterinary Vaccines Market Expected Value (2033) |
US$ 20.82 Billion |
|
Veterinary Vaccines Market Projected CAGR (2023 to 2033) |
6.2% |
Let us know your requirement to get
100% FREE customization
Global Veterinary Vaccines Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)
Increasing Penetration of Animal Immunization Driving Market Expansion
The global veterinary vaccines market is forecast to grow a robust CAGR of 6.2% between 2023 and 2033 in comparison to 6.5% registered from 2017 to 2022. The rising prevalence of zoonotic diseases, increasing demand for animal products, growing trend of pet adoption across the world, and exponential growth of the animal healthcare products market are some of the key factors driving the global veterinary vaccines market.
Similarly, the rapid expansion of the veterinary respiratory disease treatment market and the veterinary pain management drugs market due to increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
Veterinary vaccines are gaining popularity for their ability to protect animal health as well as public health as they effectively mimic naturally acquired immunity. Veterinary vaccine sales are especially high across developed nations due to increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
- Short Term (2022 to 2025): Growing efforts to develop vaccines for zoonotic diseases which are prevalent in humans as well, are set to enhance the growth of the overall veterinary vaccines market.
- Medium Term (2025 to 2028): Spending on animals has increased substantially on account of rising pet adoption rates and growing awareness about maintaining the proper health of animals. Pet owners are spending large amounts on immunizing their pets. This will continue to push the demand for pet vaccines during the forecast period and will eventually expand the global veterinary vaccines market size.
- Long Term (2028 to 2033): The introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are expected to create growth avenues within the global veterinary vaccines market during the forthcoming years.
| Historical CAGR (2016 to 2022) | 6.5% |
| Historical Market Value | US$ 10.7 Billion |
| Forecast CAGR | 6.2% |
Comparative Analysis of Adjacent Veterinary Vaccines Markets
Veterinary Vaccines Market:
|
Differentiating Aspects |
Veterinary Vaccines Market |
|
CAGR (2023 to 2033) |
6.2% |
|
Market Valuation in 2023 |
US$ 11.3 Billion |
|
Projected Market Value in 2033 |
US$ 20.82 Billion |
|
Growth Factors |
Awareness and innovation of new inoculation products. |
|
Opportunities |
Rise in revenue due to increasing purchase of veterinary vaccines online |
|
Key Trends |
Technological advancement in animal immunization |
Veterinary Therapeutics Market:
|
Differentiating Aspects |
Veterinary Therapeutics Market |
|
CAGR (2023 to 2033) |
5.8% |
|
Market Valuation in 2023 |
US$ 49.09 Billion |
|
Projected Market Value in 2033 |
US$ 86.27 Billion |
|
Growth Factors |
Increasing demand for meat and other animal products. |
|
Opportunities |
A rise in the use of drugs in livestock animals and the approval of new products. |
|
Key Trends |
Increasing trend of preventive therapeutics designed to prevent the occurrence of a disease. |
Animal Health Market:
|
Differentiating Aspects |
Animal Health Market |
|
CAGR (2023 to 2033) |
6.3% |
|
Market Valuation in 2023 |
US$ 56.33 Billion |
|
Projected Market Value in 2033 |
US$ 103.76 Billion |
|
Growth Factors |
An increase in zoonotic diseases is expected to drive the market. |
|
Opportunities |
The potential for lucrative growth opportunities in veterinary medicine can be enhanced by increasing Research and Development (R&D) activities. |
|
Key Trends |
People are adopting pets for companionship at an increasing rate. |
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors are Shaping Veterinary Vaccines Market Growth?
- Growing Importance of Developing Protozoan Parasitic Vaccines
The prevalence of a variety of animal diseases worldwide not only affects animals' health but is also dangerous for humans. For this reason, various governments are adopting mass vaccination programs for animals to stop disease transmission from animals to humans. This is expected to create significant demand for vaccines for national stockpiles.
Increasing initiatives and investments by governments around the world to tackle animal disease burden and ensure food security is anticipated to push the demand for veterinary vaccines in the future.
Currently, the veterinary healthcare industry is experiencing immense demand for protozoan parasitic vaccines and the trend is likely to escalate during the forecast period. Leading players have shifted their preference towards the production of third-generation DNA veterinary vaccines for protection against protozoan parasites due to their effective nature.
Consequently, the booming animal vaccines market worldwide will continue to create a conducive environment for veterinary vaccine suppliers during the forecast period.
- Improving Access to Advanced and Effective Vaccines is Driving Market Growth
In addition, technological advancements and the subsequent launch of animal products are critical factors. Since animal immunizations were first introduced to the general public, they have undergone major R&D developments. In the field of animal and human health, vaccinations utilizing conventionally attenuated and inactivated pathogens have made significant and critical contributions.
Nevertheless, inactivated vaccines often can only partially mimic the drawbacks of traditional animal immunization, such as the complex immunogenicity of certain bacterial pathogens. Because of these factors, recombinant vaccines have been developed, which have many advantages, including not exposing the vaccine recipient to the pathogen during vaccination.
A further driving force behind the widespread adoption of animal inoculation products is the prevention of animal diseases that can be transmitted to humans and cause epidemics.
Which Restraining Factors are Impeding Growth in the Market?
Lack of Animal Vaccination Awareness Among Smallholder Farmers
Despite its optimistic stance, the global veterinary vaccines market is facing various challenges that are likely to slow down its growth during the forecast period. Some of these factors are the lack of awareness and accessibility for smaller farmers, low healthcare awareness in some regions, and the possibility of harmful outcomes of animal vaccinations. Similarly, the high
A unified Market Research Subscription Platform, built for today's disparate research needs.
Veterinary Vaccines Market Category-Wise Insights
Why is the Demand for Attenuated Live Vaccines Increasing?
Attenuated Live Vaccines Improving Public Health by Controlling Contagious Diseases
Attenuated live vaccines remain the most preferred product in the global veterinary vaccines market and are expected to account for 24.3% of the global market share in 2023. These vaccines are high in demand due to their strong, effective, and long-lasting nature.
Which Species Type Will Emerge as a Key Market Contributor?
Increasing Livestock Animal Immunization Creating Strong Demand for Veterinary Vaccines
In terms of species, livestock animals accounted for a major revenue share in the market due to the growing need for livestock animal immunization to assure the safety of food and dairy products.
Livestock animals are essential sources of primary and secondary food items that humans utilize in their daily routine’s life. Thus, ensuring proper health of these has become a top priority, thereby prompting farmers to use healthcare products like veterinary vaccines.
Similarly, the rapid growth of the animal vaccines market across developed and developing regions will further aid the growth in this segment.
Region-wise Analysis
What Makes North America an Attractive Market for Veterinary Vaccines?
Huge Demand for Pet Vaccines Across the Continent
North America continues to shape revenue generation in the global veterinary vaccines market due to an uptick in the usage of efficacious pet vaccines in tandem with tech-advanced vaccine delivery equipment, a rise in pet adoption rates, and rapid expansion of the animal vaccines market.
Furthermore, increasing awareness among consumers regarding the prevailing veterinary vaccine market trends is likely to favor the market in North America during the forecast period.
Countries Leading in Veterinary Vaccines Market: Country-Wise Analysis
What is the Demand Outlook for Veterinary Vaccines in the USA?
Advancements in Biotechnology and Veterinary Science to Drive Market Expansion
The USA will continue to be a prominent market for veterinary vaccines due to the increasing frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.
Similarly, increasing focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology and rapid growth of the animal healthcare market is expected to create a favorable platform for the development of veterinary vaccines in the USA
Why is Germany’s Veterinary Vaccines Market Considered Lucrative within Europe?
A Growing Number of Zoonotic Diseases are Driving Market Expansion
Germany held significant revenue across the forecast years with a stable growth rate. As a result of the increasing adoption of pet animals, a growing prevalence of zoonotic diseases, a growing number of veterinary clinics, and improved healthcare infrastructure in European countries, Germany is expected to hold the first leading revenue position in Europe.
How is the Market for Veterinary Vaccines Faring in China?
Growing Innovation of Veterinary Medical Devices to Fuel Growth
China is also emerging as an opportunistic market for veterinary vaccines, underpinned by collaborative initiatives of governments and private firms to promote better animal healthcare with advanced veterinary medical devices.
Livestock and companion animal owners across the country are showing a keen interest in following regular vaccination schedules, which is expected to push the veterinary vaccine sales in the country during the forecast period.
Start-up Ecosystem: The Veterinary Vaccines Market
In the past few years, veterinary vaccination has witnessed several technological advancements. Recombinant DNA technology has been used for several immunization products, including DNA vaccines.
As a result of novel technology, the stability of the drug has also been improved, and it is easier to administer the drug. Nucleic acid is an immunization technology that falls between the life and killed approaches.
Several key players are involved in the continuous advancement of product development tools to develop innovative and efficient veterinary vaccines based on DNA cloning into a delivery plasmid or direct injection of messenger RNA.
Competitive Landscape
Some of the prominent players in the veterinary vaccines market are as follows:
- Boehringer Ingelheim GmbH,
- Zoetis Inc.
- Elanco Animal Health,
- Merck & Co., Inc.
- Bayer AG
- Virbac Group
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Others
Recent Development: Large Scale Investment in R&D Activities for the Development of New Vaccines
Leading veterinary vaccine manufacturers are continuously investing in research and development activities for introducing effective vaccines. Besides this, they have adopted various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint. For instance,
- In January 2020, Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, and Automazioni VX Inc. introduced a newly designed subcutaneous chick vaccination technology called Innoject Pro.
- In September 2020, Ceva Santé Animale increased its production capacity by three-fold for bacterial autogenous vaccines (primarily, for pigs and poultry) at its French plant.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2018 to 2023 |
|
Market Analysis |
US$ million for Value and MT for Volume |
|
Key Regions Covered |
|
|
Key Countries Covered |
The USA, Canada, Brazil, Mexico, Chile, Peru, Germany, The United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Veterinary Vaccines Market Segmentation by Category
By Product:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Disease:
- Anaplasmosis
- Canine Parvovirus
- Foot & Mouth Disease
- New Castle Disease
- Distemper Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Region:
- North America
- Latin America
- Europe
- The Middle East and Africa
- East Asia
Frequently Asked Questions
The market size of the veterinary vaccines market in 2023 is US$ 11.3 billion.
North America is a lucrative veterinary vaccines market and is expected to dominate throughout the forecast period.
The global market of veterinary vaccines is projected to reach a valuation of US$ 20.82 billion by 2033.
Accounting for a 24.3% share, the attenuated live vaccines segment leads the veterinary vaccines market.
The global market of veterinary vaccines is projected to grow at approximately a CAGR of 6.2%.
Increased awareness among farmers, the rising transmission of zoonotic diseases, surging animal ownership, and new product launches will drive the adoption of veterinary vaccines.
Table of Content
1. Executive Summary | Veterinary Vaccines Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Species Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Species Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Species Type, 2023 to 2033
5.3.1. Companion Animals
5.3.1.1. Canine
5.3.1.2. Avian
5.3.1.3. Feline
5.3.2. Livestock Animals
5.3.2.1. Aquatic
5.3.2.2. Bovine
5.3.2.3. Porcine
5.3.2.4. Ovine/Caprine
5.3.2.5. Poultry
5.3.3. Equine
5.4. Y-o-Y Growth Trend Analysis By Species Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Species Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) Analysis By Product, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product, 2023 to 2033
6.3.1. Attenuated Live Vaccines
6.3.2. Conjugate Vaccines
6.3.3. Inactivated Vaccines
6.3.4. Subunit Vaccines
6.3.5. Toxoid Vaccines
6.3.6. DNA Vaccines
6.3.7. Recombinant Vaccines
6.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Disease
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) Analysis By Disease, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Disease, 2023 to 2033
7.3.1. Anaplasmosis
7.3.2. Canine Parvovirus
7.3.3. Foot & Mouth Disease
7.3.4. New Castle Disease
7.3.5. Distemper Disease
7.3.6. Influenza
7.3.7. Porcine Reproductive & Respiratory Syndrome
7.3.8. Others
7.4. Y-o-Y Growth Trend Analysis By Disease, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ million) Analysis By Distribution Channel, 2017 to 2022
8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Distribution Channel, 2023 to 2033
8.3.1. Veterinary Clinics
8.3.2. Veterinary Hospitals
8.3.3. Veterinary Research Institutes
8.3.4. Retail Pharmacies
8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. Asia Pacific excluding Japan (APEJ)
9.3.6. Japan
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Species Type
10.2.3. By Product
10.2.4. By Disease
10.2.5. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Species Type
10.3.3. By Product
10.3.4. By Disease
10.3.5. By Distribution Channel
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Species Type
11.2.3. By Product
11.2.4. By Disease
11.2.5. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Species Type
11.3.3. By Product
11.3.4. By Disease
11.3.5. By Distribution Channel
11.4. Key Takeaways
12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. The United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Nordic countries
12.2.1.7. BENELUX
12.2.1.8. Rest Of Western Europe
12.2.2. By Species Type
12.2.3. By Product
12.2.4. By Disease
12.2.5. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Species Type
12.3.3. By Product
12.3.4. By Disease
12.3.5. By Distribution Channel
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Russia
13.2.1.2. Poland
13.2.1.3. Rest Of Eastern Europe
13.2.2. By Species Type
13.2.3. By Product
13.2.4. By Disease
13.2.5. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Species Type
13.3.3. By Product
13.3.4. By Disease
13.3.5. By Distribution Channel
13.4. Key Takeaways
14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. India
14.2.1.3. ASEAN
14.2.1.4. Australia & New Zealand
14.2.2. By Species Type
14.2.3. By Product
14.2.4. By Disease
14.2.5. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Species Type
14.3.3. By Product
14.3.4. By Disease
14.3.5. By Distribution Channel
14.4. Key Takeaways
15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.2. By Species Type
15.2.3. By Product
15.2.4. By Disease
15.2.5. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Species Type
15.3.3. By Product
15.3.4. By Disease
15.3.5. By Distribution Channel
15.4. Key Takeaways
16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022
16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest Of MEA
16.2.2. By Species Type
16.2.3. By Product
16.2.4. By Disease
16.2.5. By Distribution Channel
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Species Type
16.3.3. By Product
16.3.4. By Disease
16.3.5. By Distribution Channel
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. The USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Species Type
17.1.2.2. By Product
17.1.2.3. By Disease
17.1.2.4. By Distribution Channel
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Species Type
17.2.2.2. By Product
17.2.2.3. By Disease
17.2.2.4. By Distribution Channel
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Species Type
17.3.2.2. By Product
17.3.2.3. By Disease
17.3.2.4. By Distribution Channel
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Species Type
17.4.2.2. By Product
17.4.2.3. By Disease
17.4.2.4. By Distribution Channel
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Species Type
17.5.2.2. By Product
17.5.2.3. By Disease
17.5.2.4. By Distribution Channel
17.6. The United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Species Type
17.6.2.2. By Product
17.6.2.3. By Disease
17.6.2.4. By Distribution Channel
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Species Type
17.7.2.2. By Product
17.7.2.3. By Disease
17.7.2.4. By Distribution Channel
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Species Type
17.8.2.2. By Product
17.8.2.3. By Disease
17.8.2.4. By Distribution Channel
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Species Type
17.9.2.2. By Product
17.9.2.3. By Disease
17.9.2.4. By Distribution Channel
17.10. Nordic countries
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Species Type
17.10.2.2. By Product
17.10.2.3. By Disease
17.10.2.4. By Distribution Channel
17.11. BENELUX
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Species Type
17.11.2.2. By Product
17.11.2.3. By Disease
17.11.2.4. By Distribution Channel
17.12. Russia
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Species Type
17.12.2.2. By Product
17.12.2.3. By Disease
17.12.2.4. By Distribution Channel
17.13. Poland
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Species Type
17.13.2.2. By Product
17.13.2.3. By Disease
17.13.2.4. By Distribution Channel
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Species Type
17.14.2.2. By Product
17.14.2.3. By Disease
17.14.2.4. By Distribution Channel
17.15. India
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Species Type
17.15.2.2. By Product
17.15.2.3. By Disease
17.15.2.4. By Distribution Channel
17.16. ASEAN
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Species Type
17.16.2.2. By Product
17.16.2.3. By Disease
17.16.2.4. By Distribution Channel
17.17. Australia & New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Species Type
17.17.2.2. By Product
17.17.2.3. By Disease
17.17.2.4. By Distribution Channel
17.18. Japan
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Species Type
17.18.2.2. By Product
17.18.2.3. By Disease
17.18.2.4. By Distribution Channel
17.19. GCC countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Species Type
17.19.2.2. By Product
17.19.2.3. By Disease
17.19.2.4. By Distribution Channel
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Species Type
17.20.2.2. By Product
17.20.2.3. By Disease
17.20.2.4. By Distribution Channel
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Species Type
17.21.2.2. By Product
17.21.2.3. By Disease
17.21.2.4. By Distribution Channel
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Species Type
18.3.3. By Product
18.3.4. By Disease
18.3.5. By Distribution Channel
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boehringer Ingelheim GmbH
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Zoetis Inc.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Elanco Animal Health
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Merck & Co., Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Bayer AG
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Virbac Group
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Ceva Santé Animale
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Phibro Animal Health Corporation
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. Elanco
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. HIPRA
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033
Table 2: Global Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 3: Global Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 4: Global Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 5: Global Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 6: North America Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 7: North America Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 8: North America Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 9: North America Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 10: North America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 11: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 12: Latin America Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 13: Latin America Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 14: Latin America Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 15: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 16: Western Europe Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 17: Western Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 18: Western Europe Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 19: Western Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 20: Western Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 21: Eastern Europe Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 22: Eastern Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 23: Eastern Europe Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 24: Eastern Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 25: Eastern Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 26: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 27: APEJ Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 28: APEJ Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 29: APEJ Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 30: APEJ Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 31: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 32: Japan Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 33: Japan Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 34: Japan Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 35: Japan Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Table 36: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033
Table 37: MEA Market Value (US$ million) Forecast by Species Type, 2017 to 2033
Table 38: MEA Market Value (US$ million) Forecast by Product, 2017 to 2033
Table 39: MEA Market Value (US$ million) Forecast by Disease, 2017 to 2033
Table 40: MEA Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ million) by Species Type, 2023 to 2033
Figure 2: Global Market Value (US$ million) by Product, 2023 to 2033
Figure 3: Global Market Value (US$ million) by Disease, 2023 to 2033
Figure 4: Global Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 5: Global Market Value (US$ million) by Region, 2023 to 2033
Figure 6: Global Market Value (US$ million) Analysis by Region, 2017 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 12: Global Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 13: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 14: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 15: Global Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 16: Global Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 17: Global Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 18: Global Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 21: Global Market Attractiveness by Species Type, 2023 to 2033
Figure 22: Global Market Attractiveness by Product, 2023 to 2033
Figure 23: Global Market Attractiveness by Disease, 2023 to 2033
Figure 24: Global Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 25: Global Market Attractiveness by Region, 2023 to 2033
Figure 26: North America Market Value (US$ million) by Species Type, 2023 to 2033
Figure 27: North America Market Value (US$ million) by Product, 2023 to 2033
Figure 28: North America Market Value (US$ million) by Disease, 2023 to 2033
Figure 29: North America Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 30: North America Market Value (US$ million) by Country, 2023 to 2033
Figure 31: North America Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 34: North America Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 37: North America Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 40: North America Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 43: North America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 46: North America Market Attractiveness by Species Type, 2023 to 2033
Figure 47: North America Market Attractiveness by Product, 2023 to 2033
Figure 48: North America Market Attractiveness by Disease, 2023 to 2033
Figure 49: North America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 50: North America Market Attractiveness by Country, 2023 to 2033
Figure 51: Latin America Market Value (US$ million) by Species Type, 2023 to 2033
Figure 52: Latin America Market Value (US$ million) by Product, 2023 to 2033
Figure 53: Latin America Market Value (US$ million) by Disease, 2023 to 2033
Figure 54: Latin America Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 55: Latin America Market Value (US$ million) by Country, 2023 to 2033
Figure 56: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 59: Latin America Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 62: Latin America Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 65: Latin America Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 68: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Species Type, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Product, 2023 to 2033
Figure 73: Latin America Market Attractiveness by Disease, 2023 to 2033
Figure 74: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 76: Western Europe Market Value (US$ million) by Species Type, 2023 to 2033
Figure 77: Western Europe Market Value (US$ million) by Product, 2023 to 2033
Figure 78: Western Europe Market Value (US$ million) by Disease, 2023 to 2033
Figure 79: Western Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 80: Western Europe Market Value (US$ million) by Country, 2023 to 2033
Figure 81: Western Europe Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 84: Western Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 87: Western Europe Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 90: Western Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 93: Western Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 94: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 96: Western Europe Market Attractiveness by Species Type, 2023 to 2033
Figure 97: Western Europe Market Attractiveness by Product, 2023 to 2033
Figure 98: Western Europe Market Attractiveness by Disease, 2023 to 2033
Figure 99: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: Eastern Europe Market Value (US$ million) by Species Type, 2023 to 2033
Figure 102: Eastern Europe Market Value (US$ million) by Product, 2023 to 2033
Figure 103: Eastern Europe Market Value (US$ million) by Disease, 2023 to 2033
Figure 104: Eastern Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 105: Eastern Europe Market Value (US$ million) by Country, 2023 to 2033
Figure 106: Eastern Europe Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 109: Eastern Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 112: Eastern Europe Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 115: Eastern Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 118: Eastern Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 121: Eastern Europe Market Attractiveness by Species Type, 2023 to 2033
Figure 122: Eastern Europe Market Attractiveness by Product, 2023 to 2033
Figure 123: Eastern Europe Market Attractiveness by Disease, 2023 to 2033
Figure 124: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 126: APEJ Market Value (US$ million) by Species Type, 2023 to 2033
Figure 127: APEJ Market Value (US$ million) by Product, 2023 to 2033
Figure 128: APEJ Market Value (US$ million) by Disease, 2023 to 2033
Figure 129: APEJ Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 130: APEJ Market Value (US$ million) by Country, 2023 to 2033
Figure 131: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 132: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: APEJ Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 135: APEJ Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 136: APEJ Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 137: APEJ Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 138: APEJ Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 139: APEJ Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 140: APEJ Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 141: APEJ Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 142: APEJ Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 143: APEJ Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 144: APEJ Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 145: APEJ Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 146: APEJ Market Attractiveness by Species Type, 2023 to 2033
Figure 147: APEJ Market Attractiveness by Product, 2023 to 2033
Figure 148: APEJ Market Attractiveness by Disease, 2023 to 2033
Figure 149: APEJ Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 150: APEJ Market Attractiveness by Country, 2023 to 2033
Figure 151: Japan Market Value (US$ million) by Species Type, 2023 to 2033
Figure 152: Japan Market Value (US$ million) by Product, 2023 to 2033
Figure 153: Japan Market Value (US$ million) by Disease, 2023 to 2033
Figure 154: Japan Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 155: Japan Market Value (US$ million) by Country, 2023 to 2033
Figure 156: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 157: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 158: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 159: Japan Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 160: Japan Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 161: Japan Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 162: Japan Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 163: Japan Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 164: Japan Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 165: Japan Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 166: Japan Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 167: Japan Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 168: Japan Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 169: Japan Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 170: Japan Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 171: Japan Market Attractiveness by Species Type, 2023 to 2033
Figure 172: Japan Market Attractiveness by Product, 2023 to 2033
Figure 173: Japan Market Attractiveness by Disease, 2023 to 2033
Figure 174: Japan Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 175: Japan Market Attractiveness by Country, 2023 to 2033
Figure 176: MEA Market Value (US$ million) by Species Type, 2023 to 2033
Figure 177: MEA Market Value (US$ million) by Product, 2023 to 2033
Figure 178: MEA Market Value (US$ million) by Disease, 2023 to 2033
Figure 179: MEA Market Value (US$ million) by Distribution Channel, 2023 to 2033
Figure 180: MEA Market Value (US$ million) by Country, 2023 to 2033
Figure 181: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 184: MEA Market Value (US$ million) Analysis by Species Type, 2017 to 2033
Figure 185: MEA Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033
Figure 187: MEA Market Value (US$ million) Analysis by Product, 2017 to 2033
Figure 188: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 190: MEA Market Value (US$ million) Analysis by Disease, 2017 to 2033
Figure 191: MEA Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 193: MEA Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033
Figure 194: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 195: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 196: MEA Market Attractiveness by Species Type, 2023 to 2033
Figure 197: MEA Market Attractiveness by Product, 2023 to 2033
Figure 198: MEA Market Attractiveness by Disease, 2023 to 2033
Figure 199: MEA Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
